본문으로 바로가기

의료진 소개

박소정 의사

박소정 교수


호흡기내과, 호흡기센터 관심의료진 등록

전문 진료 분야

중환자치료, 급성호흡곤란증후군, 패혈증, 만성폐쇄성 폐질환, 기관지확장증, 늑막질환 및 기타 폐질환, 코로나 후유증 클리닉

진료 일정

학력 및 경력사항

학력사항

  • 울산대학교 의학박사
  • 울산대학교 의학석사
  • 인제대학교 의과대학 졸업

교육 및 연구경력

  • 2021-현재  | 이대목동병원 호흡기내과 조교수
  • 2019-2021  | 이대목동병원 호흡기내과 임상조교수
  • 2018-2019  | 동탄성심병원 호흡기내과 임상조교수
  • 2017-2018  | 서울아산병원 호흡기내과 임상전임강사
  • 2016  | 미국 Yale School of Medicine laboratory associate
  • 2015-2017  | 서울아산병원 호흡기내과 임상강사
  • 2011-2015  | 서울아산병원 내과 전공의
  • 2010-2011  | 서울아산병원 인턴

기타 학술 관련 경력

  • 대한중환자의학회 평생회원
  • 대한폐암학회 정회원
  • 대한결핵및호흡기학회 정회원
  • 대한내과학회 정회원

논문

  •  Risk factors for mortality among mechanically ventilated patients requiring pleural drainage.  Int J Gen Med. 2022-02. 
  •  Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer.  Journal of Clinical Medicine. 2022, v.11 no.9, 2391. 
  •  Stratifying non-small cell lung cancer patients using an inverse of the treatment decision rules: validation using electronic health records with application to an administrative database.  BMC Medical Informatics and Decision Making. 2023, v.23 no.1, 3. 
  •  Effectiveness of rapid response team on in-hospital mortality in patients with hematologic malignancy.  Quality Improvement in Health Care. 2021. 
  •  Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007-2012 KNHANES.  J Thorac Dis. 2021-10. 
  •  Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types .  BMC Cancer. 2021-01. 
  •  Histologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis.  Sci Rep. 2020-12. 
  •  Diagnostic yield of additional conventional transbronchial lung biopsy following radial endobronchial ultrasound lung biopsy for peripheral pulmonary lesions.  Thorac Cancer. 2020-06. 
  •  Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study.  PLoS One . 2020-02. 
  •  Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.  Cancer Letters. 2020-01. 
  •  Effect of medical thoracoscopy-guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non-small cell lung cancer: A pilot study.  Thorac Cancer. 2019-10. 
  •  CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.  Cell Oncol . 2019-08. 
  •  Risk factors associated with an increase in the size of ground glass lung nodules on chest computed tomography.  Thorac Cancer. 2019-07. 
  •  Exceptional pemetrexed sensitivity can predict therapeutic benefit from subsequent chemotherapy in metastatic non-squamous non-small cell lung cancer.  J Cancer Research Clin Oncol. 2019-07. 
  •  Survival benefit of first-generation epidermal growth factor receptor-tyrosine kinase inhibitors in female with advanced lung cancer.  Tumori. 2019-06. 
  •  Mobile phone app-based pulmonary rehabilitation for chemotherapy-treated patients with advanced lung cancer: Pilot study.  JMIR Mhealth Uhealth. 2019-02. 
  •  Chest radiography surveillance for lung cancer: Results from a National Health Insurance database in South Korea.  Lung cancer. 2019-02. 
  •  Mortality and Prognostic Prediction in Very Elderly Patients With Severe Pneumonia.  J Intensive Care Med. 2019-01. 
  •  Effect of vitamin D deficiency in Korean patients with acute respiratory distress syndrome.  Korean J Intern Med. 2018-11. 
  •  Non-small cell lung cancer with resistance to EGFR-TKI therapy: CT characteristics of T790M mutation-positive cancer.  Radiology. 2018-10. 
  •  Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis.  Respir Res. 2018-10. 
  •  Correlation between progression-free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced-stage EGFR-mutated non-small cell lung cancer.  Thorac Cancer. 2018-09. 
  •  In vitro MIC values of rifampin and ethambutol and treatment outcome in Mycobacterium avium complex lung disease.  Antimicrob Agents Chemother. 2018-09. 
  •  Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.  Respir Med . 2017-12. 
  •  Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid.  Clin Chem Lab Med . 2017-08. 
  •  Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed.  BMC cancer . 2016-07. 
  •  Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer .  Oncotarget. 2016-04. 
  •  Survival benefit of pemetrexed in lung adenocarcinoma patients with anaplastic lymphoma kinase gene rearrangements.  Clin Lung Cancer . 2015-09. 
  •  Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy.  Int J Tuberc Lung Dis . 2015-03.